Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

IHT2: Humana chief says Americans need to get healthier to curb crisis

Behavior modification can play a role in improving healthcare for Americans, Humana Chairman, President and CEO Michael B. McCallister said during his keynote address Reinventing Healthcare: From Covering Sickness to Creating Well-Being, at the Institute for Health Technology Transformation (iHT2) Summit in New York City on Sept. 20.

KLAS: ACOs will be the future of healthcare

While the accountable care organization (ACO) model may not be formally pursued from a Medicare ACO designation standpoint, the majority of providers agree that accountable care is where the future of healthcare is going, according to a new report from market researcher KLAS.

Four payors pool data to assess nationwide costs, utilization

The Health Care Cost Institute (HCCI), a health research initiative led by payors Aetna, Humana, Kaiser Permanente and UnitedHealthcare, was launched to allow researchers and policymakers access to a collection of health plan and government payor data. The HCCI said this initiative will offer new insights into healthcare costs, utilization and intensity, as well as inform the public policy process and assist in developing new solutions to long-term problems confronting the healthcare system.

HFSA: Knowing hospitalization history can impact long-term mortality

BOSTONFor low-risk patients, mortality increases when the number of prior heart failure (HF) hospitalizations increase, however, long-term mortality impacts differ by baseline risk of death, Scott L. Hummel, MD, of the University of Michigan Health System in Ann Arbor, Mich., said during the rapid fire abstracts session Sept. 19 at the 15th annual Heart Failure Society of America (HFSA) scientific meeting. If HF hospitalization data are acquired, HF resources may be better utilized.

Jones becomes Meditech's lead physician

Steven Jones, MD, a family practice physician, will join Meditech as the company's lead physician for electronic health record (EHR) development efforts, as well as across multiple clinical projects.

HFSA: HF readmissions continue to reflect racial disparities

BOSTONDisparities are rampant in heart failure care, Karen E. Joynt, MD, MPH, of the Harvard School of Public Health and Brigham and Womens Hospital in Boston, said during a presentation Sept. 19 at the 15th annual Heart Failure Society of America (HFSA) scientific meeting. When it comes to monitoring and reporting readmission rates, patient and community factors are forgotten and measurements center instead on the hospital and its practices.

U of Mich. creates computational medicine, bioinformatics dept

The University of Michigan Medical School is establishing a computational medicine and bioinformatics department, following action by the Ann Arbor-based universitys board of regents.

ACC: Cardiologists on the EMR incentive uptake

Fifty-five percent of cardiologists who responded to an American College of Cardiology (ACC) survey are either participating or plan to participate in the Centers for Medicare & Medicaid Services (CMS) EHR Incentive Program. Thirty-four percent have already registered, according to a survey published in the colleges Cardiology magazine.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.